Abstract:Abstract BACKGROUND DNA methylation is an essential component for integrative diagnosis of gliomas. Methylation subtype prediction of gliomas is currently done via sample extraction of high-quality DNA (~1ug), methylome profiling, followed by probe identification, curation and subsequent analysis via different random forest classifiers. However, the DNA methylation classification is not always available for all the samples. Examples include when the existing material is not suitable for methylation profiling or the sample is very limiting. Therefore, we hypothesized that Raman spectroscopy might be suitable to predict the glioma methylome, based upon its ability to create a molecular fingerprint of the tumor and would provide biological insights unknown before. METHODS Coherent Raman Spectroscopy was used for molecular fingerprinting of the regions of interest using 1mm2 FFPE tissue spots from 39 patient samples with LGm1 to LGm6 methylation subtypes. Spectral information was then used to train a convolutional neural network (CNN) and develop a prediction algorithm, capable of detecting the glioma methylation subtypes. 70 % of the dataset was used for model training while the remaining 30% for validation. Oversampling was used to obtain a subtype-balanced data distribution. In addition, supervised wrapper methods and random forests were used to identify the top 50 most discriminatory Raman frequencies out of 1738. RESULTS We demonstrate that Raman spectroscopy can accurately and rapidly classify gliomas according to their methylation subtype from achieved FFPE samples, which are routinely present in pathological laboratories as a complementary mean to obtain this important classification when other analyses are not available. The most discriminatory frequencies show differential spectral intensities depending upon the glioma subtypes across the larger areas of the tissue. CONCLUSIONS The non-destructive nature of this method and the ability to be applied on FFPE samples directly, allows the histopathologist to reuse of the same slide for subsequent staining and downstream analyses.

DNA methylation-based epigenetic signatures predict somatic genomic alterations in gliomas

Transcriptomic Profiling Identifies a Nucleotide Metabolism-Related Signature with Prognostic Power in Gliomas

Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes

Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers

Clinical and Biological Significances of a Methyltransferase-Related Signature in Diffuse Glioma.

Radiogenomic profiling of global DNA methylation associated with molecular phenotypes and immune features in glioma

DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas

Machine-learning operations streamlined clinical workflows of DNA methylation-based CNS tumor classification.

Diagnostic classification based on DNA methylation profiles using sequential machine learning approaches.

DNA Methylation Analysis Identifies Patterns in Progressive Glioma Grades to Predict Patient Survival

Metabolism-Associated DNA Methylation Signature Stratifies Lower-Grade Glioma Patients and Predicts Response to Immunotherapy

Global DNA Methylation Patterns in Human Gliomas and Their Interplay with Other Epigenetic Modifications

Novel epigenetic signature of DNA damage response genes for prognostication and immunophenotype of non-G-CIMP glioblastomas

Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact

Molecular and clinical characterization of 5mC regulators in glioma: results of a multicenter study

TBMT-02. APOLLO: RAMAN-BASED PATHOLOGY OF MALIGNANT GLIOMA

Global DNA Methylation Profiling Reveals Chromosomal Instability in IDH-mutant Astrocytomas

Biom-67. Differential Dna Methylation Patterns In The Csf Of Patients With Diffuse Gliomas

Bioinformatic Analysis of Gene Expression and Methylation Regulation in Glioblastoma

Distinguishing Glioblastoma Subtypes by Methylation Signatures

Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas.